(Q38859130)

7 September 2017

1 reference

title

Community-acquired pneumonia related to intracellular pathogens (English)

1 reference

7 September 2017

0 references

7

1 reference

7 September 2017

6

Tobias Welte

1 reference

7 September 2017

5

James Chalmers

1 reference

7 September 2017

Catia Cillóniz

1

1 reference

7 September 2017

Antoni Torres

series ordinal

2

1 reference

7 September 2017

Michael Niederman

series ordinal

3

1 reference

7 September 2017

Menno van der Eerden

series ordinal

4

1 reference

7 September 2017

publication date

8 June 2016

1 reference

7 September 2017

published in

Intensive Care Medicine

1 reference

7 September 2017

volume

42

1 reference

7 September 2017

issue

9

1 reference

7 September 2017

page(s)

1374-1386

1 reference

Burden of community-acquired pneumonia in North American adults

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Recent advances in community-acquired pneumonia: inpatient and outpatient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Towards a sensible comprehension of severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Atypical pathogens and respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Risk factor analysis of acute respiratory distress syndrome among hospitalized patients with Chlamydophila pneumoniae pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

A worldwide perspective of atypical pathogens in community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Comparison of Legionella longbeachae and Legionella pneumophila cases in Scotland; implications for diagnosis, treatment and public health response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Legionella longbeachae and legionellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

21 January 2018

An update on Legionella.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Clinical and economic burden of community-acquired pneumonia among adults in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Risk factors for sporadic community-acquired Legionnaires' disease. A 3-year national case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Legionnaires' disease incidence and risk factors, New York, New York, USA, 2002-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Epidemiology and Aetiology of Community-acquired Pneumonia (CAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Impact of age and comorbidity on cause and outcome in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Two fatal cases of psittacosis caused by Chlamydophila psittaci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Rapid metagenomic diagnostics for suspected outbreak of severe pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Distinctive features between community-acquired pneumonia (CAP) due to Chlamydophila psittaci and CAP due to Legionella pneumophila admitted to the intensive care unit (ICU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Chlamydia psittaci: update on an underestimated zoonotic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Q fever--a review and issues for the next century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Molecular epidemiology of Coxiella burnetii from ruminants in Q fever outbreak, the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

The 2007–2010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Q fever is underestimated in the United States: a comparison of fatal Q fever cases from two national reporting systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Coxiella burnetii (Q fever) as a cause of community-acquired pneumonia during the warm season in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Characteristics of hospitalized acute Q fever patients during a large epidemic, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Probable Person-to-Person Transmission of Legionnaires' Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Relationships between the varied ciliated respiratory epithelium abnormalities and severity of Mycoplasma pneumoniae pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Mycoplasma pneumoniae and its role as a human pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Chlamydia species as a cause of community-acquired pneumonia in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

An important outbreak of human Q fever in a Swiss Alpine valley.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Ruling out Legionella in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

21 January 2018

Chlamydophila pneumoniae

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Identification of legionella in clinical samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Systematic review and metaanalysis: urinary antigen tests for Legionellosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Single tube real time PCR for detection of Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella pneumophila from clinical samples of CAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Molecular genetic methods for the diagnosis of fastidious microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Clinical Efficacy of Moxifloxacin Versus Comparator Therapies for Community-Acquired Pneumonia Caused byLegionellaspp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Antibiotic treatment in pneumonia due to Q fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Time-course of antibody responses against Coxiella burnetii following acute Q fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Comparison of serological methods with PCR-based methods for the diagnosis of community-acquired pneumonia caused by atypical bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Impact of routine systematic polymerase chain reaction testing on case finding for Legionnaires' disease: a pre-post comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

The Role of Atypical Pathogens in Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4394-4

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

21 January 2018

1 reference

12 December 2020

Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults

1 reference

12 December 2020

Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment

1 reference

12 December 2020

Community-acquired pneumonia in outpatients: aetiology and outcomes

1 reference

12 December 2020

A Study on the Clinical Course and Antimicrobial Susceptibility of Mycoplasma pneumoniae in a Community Hospital

1 reference

12 December 2020

Cluster of Legionnaires disease cases caused by Legionella longbeachae serogroup 1, Scotland, August to September 2013.

1 reference

12 December 2020

Legionella pneumonia in cancer patients

1 reference

12 December 2020

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Severe pneumonia from psittacosis in a bird-keeper

1 reference

12 December 2020

Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit

1 reference

12 December 2020

Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture

1 reference

12 December 2020

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

1 reference

12 December 2020

Epidemiological features of Coxiella burnetii infection in England and Wales: 1984 to 1994.

1 reference

12 December 2020

Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults

1 reference

12 December 2020

Q fever: epidemiology, diagnosis, and treatment

1 reference

12 December 2020

Activity of telithromycin and comparators against isolates of Legionella pneumophila collected from patients with community-acquired respiratory tract infections: PROTEKT Years 1-5

1 reference

12 December 2020

The science of selecting antimicrobials for community-acquired pneumonia (CAP).

1 reference

12 December 2020

Detection of Legionella species in respiratory specimens using PCR with sequencing confirmation

1 reference

12 December 2020

Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.

1 reference

12 December 2020

Microbial aetiology of community-acquired pneumonia and its relation to severity

1 reference

12 December 2020

Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group

1 reference

12 December 2020

10.1007/S00134-016-4394-4

Identifiers

DOI

1 reference

7 September 2017

1 reference